TBCH — what changed in the latest 10-Q

Text added vs the prior filing · source: 10-Q · 2026-08-06

• not authorize the President to impose the challenged tariffs. Following the Supreme Court’s decision and related proceedings, the U.S. Court of International Trade issued orders establishing processes and procedures affecting potential refunds of IEEPA-related duties.

• During the three months ended June 30, 2026, we received tariff refunds totaling $8.2 million from the CBP related to previously paid import duties, all of which were recorded as an increase to cash. Of the total amount received, $4.3 million related to tariffs recognized in cost of revenue during t…

• Various modifications to U.S. tariff policy have been announced since the Supreme Court’s decision, and newly imposed tariffs may affect the Company’s future cost of inventory and operating results. Although the impact to the Company of ongoing changes in U.S. and international tariff policy remains…

• For the three months ended June 30, 2026, gross margin increased to 38.8% from 32.2% in the comparable prior year period. The increase was primarily due to a $4.3 million reduction to cost of revenue related to a tariff refund recognized during the three months ended June 30, 2026, of which $3.1 mil…

• Comparison of the Six Months Ended June 30, 2026 to the Six Months Ended June 30, 2025

Text removed vs the prior filing · source: 10-Q · 2026-05-07

• Act (“IEEPA”) were unconstitutional. Following this decision, the U.S. Court of International Trade ordered U.S. Customs and Border Protection (“CBP”) to establish a process for issuing refunds related to these tariffs.

• On April 20, 2026, CBP launched an online portal for the submission of IEEPA-related tariff refund requests. Submitted claims will be reviewed by CBP to determine eligibility prior to the issuance of any refunds. In response to the Supreme Court’s ruling, the U.S. implemented a new 10% tariff on all…

• For the three months ended March 31, 2026, gross margin decreased to 26.8% from 36.6% in the comparable prior year period primarily due to decline in net revenues relative to cost of goods sold. During the three months ended March 31, 2026, gross margin was adversely affected compared with the prior…

• Selling and marketing expenses decreased by $0.2 million, or 1.5% for the three months ended March 31, 2026 as compared to the same period in the prior year primarily due to lower employee compensation cost.

• Research and development costs increased by $0.6 million or 14.6% for the three months ended March 31, 2026 as compared to the same period in the prior year due to engineering costs related to new products.

Text added vs the prior filing · source: 10-Q · 2026-08-06

• On May 26, 2026, Katherine Scherping, a former member of the Board who was serving as a director at the time of the termination, terminated a Rule 10b5-1 trading arrangement that was intended to satisfy the affirmative defense under Rule 10b5-1(c) under the Exchange Act (such arrangement, a “10b5-1 …

• Except as described above, none of our other directors or executive officers adopted or terminated a 10b5-1 Plan, or a "non-Rule 10b5-1 trading arrangement" (as each term is defined in Item 408 of Regulation S-K) during the three months ended June 30, 2026.

Text removed vs the prior filing · source: 10-Q · 2026-05-07

• On March 17, 2026, Andrew Wolfe, a member of the Board, entered into a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act (such arrangement, a “10b5-1 Plan”). Mr. Wolfe’s 10b5-1 Plan provides for the potential sale of up to 24…

• On March 23, 2026, Katherine Scherping, a member of the Board, entered into a 10b5-1 Plan. Ms. Scherping’s 10b5-1 Plan provides for the potential sale of up to 13,465 shares of common stock in amounts and prices set forth in the plan. Ms. Scherping’s 10b5-1 Plan terminates on March 23, 2027, or date…

• Except as described above, none of our other directors or executive officers adopted or terminated a 10b5-1 Plan, or a "non-Rule 10b5-1 trading arrangement" (as each term is defined in Item 408(a) of Regulation S-K) during the three months ended March 31, 2026.